Hostname: page-component-6766d58669-tq7bh Total loading time: 0 Render date: 2026-05-19T03:21:34.444Z Has data issue: false hasContentIssue false

Nasopharyngeal amyloidosis: an unusual cause for epistaxis

Published online by Cambridge University Press:  16 June 2009

M A Oluk*
Affiliation:
Department of Haematology, West Wales General Hospital, Carmarthen, Wales, UK
J Murphy
Affiliation:
Department of Haematology, West Wales General Hospital, Carmarthen, Wales, UK
*
Address for correspondence: Dr Margaret Atim Oluk, Flat 1, 4A Chalybeate Street, Aberystwyth, Wales SY23 1HS, UK. Fax: 01970 625 059 E-mail: Oluk2000@hotmail.co.uk

Abstract

Objective:

We report the first case of nasal and nasopharyngeal amyloidosis secondary to multiple myeloma; this case also represents the fourth report of systemic nasal or nasopharyngeal amyloidosis.

Method:

Case report and review of the world literature concerning nasal and nasopharyngeal amyloidosis epidemiology, presentation and management.

Results:

Nasal and nasopharyngeal amyloidosis is rare. The presentation, clinical course and treatment are discussed for the presented patient. The amyloid tumour, which recurred in correlation with the progressive transformation of the multiple myeloma, was treated surgically. Subsequent localised radiotherapy decreased the size and growth rate of the tumour.

Conclusion:

Amyloid should be considered as a cause of resistant or recurrent epistaxis provided a mass lesion is seen on radiological imaging. Radiotherapy may be a treatment option in nasal and nasopharyngeal amyloidosis.

Information

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable